Adverum Biotechnologies, Inc.
ADVMNASDAQHealthcare
$4.36
+$0.00(+0.00%)
Market Cap$96257756
P/E Ratio—
52W High$6.07
52W Low$1.78
Adverum Biotechnologies, Inc.（ADVM）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ADVM · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.00M | $3.60M | $0.00M | $7.50M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $4.16M |
| Gross Profit | $1.00M | $3.60M | $0.00M | $7.50M | ($4.16M) |
| Gross Margin %(computed) | 100.00% | 100.00% | — | 100.00% | — |
| Operating Expenses | |||||
| R&D Expenses | $77.04M | $77.49M | $99.28M | $89.18M | $73.31M |
| G&A Expenses | $63.12M | $55.06M | $57.86M | $64.44M | $44.64M |
| Total Operating Expenses | $140.16M | $132.54M | $157.13M | $153.62M | $113.79M |
| Operating Income | ($139.16M) | ($128.94M) | ($157.13M) | ($146.12M) | ($117.95M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($130.93M) | ($123.19M) | ($154.46M) | ($145.54M) | ($116.39M) |
| Income Tax Expense | $0.00M | ($1.08M) | $0.07M | $0.00M | $1.11M |
| Net Income | ($130.93M) | ($122.12M) | ($154.54M) | ($145.54M) | ($117.51M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-6.62 | $-2.02 | $-2.67 | $-1.48 | $-1.26 |
| Wtd Avg Shares | 19.78M | 57.98M | 57.98M | 98.36M | 93.23M |
| EBITDA | ($135.51M) | ($123.30M) | ($150.61M) | ($141.48M) | ($112.23M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Adverum Biotechnologies, Inc.
关于Adverum Biotechnologies, Inc.（ADVM）损益表
Adverum Biotechnologies, Inc.（ADVM）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，ADVM实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.13B)（净利率-13092.70%）。
常见问题
ADVM · 4 问Adverum Biotechnologies, Inc.（ADVM）2024财年营收为$0.00B，同比down72.2%。
ADVM revenueADVM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09